RE:RE:RE:Just jumped in for another 5000---at 0.29--- 9942apophis ... Indeed, yesterday's new clinical data and efficacy results have been integrated within the financial results. So the low visibility to the outside world.
My take is that TLT is playing conservative, low profile, ahead of the FDA application, to not put the cart before the horse as one accurately mentioned recently, by respect for the FDA regulators. You don't trumpet in advance or try to substitute yourself and you avoid any sense of pressure on the regulators. Let them do their job.
Ee all know that the efficacy numbers point to a new treatment options for those facing cystectomy, after having tried everything available. Now, they could try this new treatment with very good chances of saving their bladders. All this, via 2 one-hour instillation, with no SAE, when compared to the 18-24 instillations they received before facing cystectomy.
Once the FDA grant us a designation, it will make the news, on all news wires. That will be our moment of real visibility and credibility.